focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: -74.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Volatility rockets ahead of U.S. Senate runoffs

Mon, 04th Jan 2021 18:43

* Wall Street's three main equity indexes down ~1.6%
* Real estate weakest S&P sector; energy shows gains
* Dollar up, crude down; spot gold jumps
* US 10-Year yield ~0.91%

Jan 4 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

VOLATILITY ROCKETS AHEAD OF U.S. SENATE RUNOFFS
Wall Street's "fear gauge" is soaring as investors fret over
the outcome of two Senate runoffs in Georgia.
The races will determine whether Republicans or Democrats
control Congress and hence could influence the agenda of
President-elect Joe Biden's administration. A "blue sweep," or
Democratic control, could pave the way for greater corporate
regulation and higher taxes, though also for greater fiscal
spending.
John Stoltzfus, chief investment strategist at Oppenheimer
Asset Management, wrote on Monday that he expects the S&P 500
to drop 6% to 10% if Democrats take both Senate seats.
Other investors appear to be bracing for a negative scenario
as well. The Cboe Volatility Index, last up more than 4
points at around 27, is on track for its biggest one-day jump
since late October.
The VIX futures curve, which reflects longer-term
expectations for market gyrations, has also inverted for the
first time since the U.S. presidential election in November. An
inversion of the curve suggests that investors view the
short-term as more uncertain than the longer-term.
Yet the gap between historical volatility and implied
volatility is near its widest level over the past two years for
ETFs tracking the S&P 500 and the Nasdaq 100, according
to data from Susquehanna Financial Group. In other words,
investors are bracing for market moves much greater than those
that have occurred recently.
ETFs tracking the technology and healthcare sectors, which
could face greater regulation under a "blue sweep," also have
large gaps between historical and implied volatility.
So do ETFs tied to silver and oil. Christopher Murphy,
co-head of derivatives strategy at Susquehanna, said
commodity-focused ETFs have recently seen a flurry of activity
as some investors hedge against the possibility of higher
inflation as a result of greater fiscal stimulus.
Arnim Holzer, macro and correlation defense strategist at
EAB Investment Group, has recommended that his clients buy calls
on a silver ETF and puts on a long-duration Treasury ETF
. Those tactics would benefit from a rise in silver
prices and Treasury yields.
Such trades "look like excellent inflation fear hedges," he
wrote.
(April Joyner)
*****

BITCOIN: THAT "TOO FAR, TOO FAST" LOOK AGAIN? (1242 EST/1742
GMT)
Bitcoin has kicked off the new year with quite a
swing. After rallying around 20% in just the first 3 days of the
year, the cryptocurrency slid as much as 20% Monday. It has
since snapped off its low, and is now showing a loss of around
7% for the day.
In any event, bitcoin was one of 2020's star performers,
with an advance of nearly 305% on a closing basis. That thrust,
however, was a far-cry from its 2017 gain of 1,336% or its 2013
advance of 5,428%.
Nevertheless, with last year's surge, bitcoin's weekly chart
has once again taken on that parabolic look, that can suggest a
market may be rising too far, too fast:




Indeed, a parabolic rise is an exponential move, where the
angle of ascent increases to such a point, it becomes
unsustainable. This can lead to a very sharp reversal once the
parabolic curve is broken.
This because a parabolic rise can be the result of extreme
greed, and/or manic behavior, on the part of investors and
traders.
Of note, after its stellar gains of 2013 and 2017, the
following years, bitcoin suffered. It lost around 56% in 2014,
and 73% in 2018.
For some additional perspective, it might be worth noting
that leading up to the Nasdaq's Y2K top, the tech-laden
index surged about 86% in 1999. Although, in many ways just a
blip compared the kind of rises bitcoin has seen, it was, and
remains, the Nasdaq's best yearly gain ever. Nasdaq did not see
a new high until 2015.
Spot gold's 1979 rise of nearly 127%, which was the
year before its 1980 top, stands as its best yearly gain ever.
After its 1980 top, gold entered a multi-decade bear market, and
did not see a new high again until 2007.
Clearly, there is no absolute level of increase, or rate of
ascent, that signaled the end to the highlighted advances in any
of these markets. Nevertheless, the extent of the rallies
mentioned were especially sharp on a relative basis.
Thus, it now remains to be seen if bitcoin, in the wake of
its 3rd best yearly gain ever, can sustain its thrust, or if
another burnout, awaits.

(Terence Gabriel)
*****

SEMIS, ENERGY OUTPERFORM IN A BLEAK MARKET (1206 EST/1706
GMT)
While U.S. stocks are a sea of red on Monday, the
semiconductor sector was the only gainer for much of the
morning. That said, even chips have lost their lustre, though
they are still among the best performers on a relative basis in
a dreary market.
The energy sector is also holding up better than
much of the market after in early afternoon trade.
One reason chips were doing better than most on Monday
morning may be uncertainty about the future, according to Kim
Forrest, chief investment officer at Bokeh Capital Partners in
Pittsburgh:
"It’s the easy thesis: We don’t know what the future holds,
with respect to what technology will be a winner this year, but
we know there is demand for more computers and connection from
the analog to the digital world."
These uncertainties about the future, including Tuesday's
Georgia Senate run-off election as well as restrictions that
could come from rising covid cases, cast a pall over the broader
market.
And after rising as much as 2.7% earlier in the session,
confidence even in semis waned sharply and the Philadelphia
Semiconductor index was last down 0.5%. Even Micron
Technology, couldn't resist the general flow and was last
down ~1% even after its positive news in the form of price
traget increases from UBS to $90 from $82 and from Morgan
Stanley to $88 from $80.
In comparison Wall Street's three major indexes are all down
around 2%, and while the broad S&P technology sector
is down 2.3%. Gold is up 2% gain.
Here is you mid-session snapshot:



(Sinéad Carew)
*****

IN WITH THE NEW: 2021 STARTS WITH STRONG PMI, CONSTRUCTION
DATA (1105 EST/1605 GMT)
Two indicators released on Monday helped investors ease
their way into the new year with welcome signs of economic
recovery from the pandemic recession, now entering its 12th
month.
The National Bureau of Economic Research determined the
United States economy entered recession in February 2020.
Activity in the U.S. manufacturing sector grew in December
at a faster pace than previously reported, according to global
financial information firm IHS Markit.
Markit's final purchasing managers index (PMI)
hit a reading last month of 57.1, finishing a tumultuous year at
a six-year high.
The data marks an increase from the 56.5 rate originally
reported. A PMI number above 50 indicates activity in the sector
expanded from the prior month.
"Producers of machinery and equipment reported sustained
strong demand, suggesting companies are increasing their
investment spending," writes Chris Williamson, chief business
economist at Markit.
The news, however, is not all rainbows and lollipops.
"The survey also highlights how manufacturers are now not
only facing weaker demand conditions due to the pandemic, but
are also seeing COVID-19 disrupt supply chains further, causing
shipping delays," Williamson adds. "These delays are limiting
production capabilities as well as driving producers' input
prices sharply higher, adding to the sector's woes."

On Tuesday, the Institute for Supply Management's (ISM) more
closely-watched PMI report is expected to come in at 56.6.
ISM and Markit PMI differ in the weight they give
subcomponents such as new orders, employment and inventories.
The chart below shows how widely the two indexes can differ
although in recent months they appear closer to agreeing:

A separate report from the Commerce Department showed
expenditures on construction projects increased by
0.9% in November, a hair slower than the 1% analysts expected.

Still, this is on the back of October's upwardly-revised
1.6% growth.
The gains were driven by a 2.7% jump in spending on
residential projects, as homebuilders struggle to keep pace
spiking demand for lower-density communities and work-from-home
office space amid pandemic restrictions.
The headline number was limited, however, by decreases in
nonresidential and public projects, which eased by 0.8% and
0.2%, respectively.
Strong residential activity has driven construction past
pre-pandemic levels, but non-residential outlays remain nearly
6% below their early 2020 pace," says Nancy Vanden Houten, lead
U.S. economist at Oxford Economics.

Market participants were unimpressed however and all three
major U.S. stock indexes reversed early gains in morning
trading.
(Stephen Culp)
*****

WALL STREET TAKES A NEW YEAR'S DIP TO KICK OFF 2021 (1025
EST/1525 GMT)
Wall Street's three major averages are having a bumpy start
to the trading year, starting higher before losing gains.
One thing on investors minds was Tuesday's twin U.S. Senate
runoff elections in Georgia, which will determine control of the
chamber and, effectively, the fate of President-elect Joe
Biden's agenda including rewriting the tax code, boosting
stimulus and infrastructure spending.
Encouraging progress in COVID-19 vaccines came with news of
surging cases and restrictions. Moderna is up almost 4%
after raising its 2021 vaccine output forecast.
But as Britain was first to began vaccinations with Oxford
University and AstraZeneca's COVID-19 shot on Monday, a
new surge of cases threatened to overwhelm its hospitals.
Scottish First Minister Nicola Sturgeon imposed the most
stringent lockdown since last spring.
In the United States the U.S. Centers for Disease Control
and Prevention (CDC) on Sunday reported 349,246 deaths from the
new coronavirus, a rise of 2,321 deaths from its previous count.
Vaccinations here have fallen far short of early
targets, as officials had hoped to have 20 million people
vaccinated by the end of the 2020.
Among S&P 500 major industry sectors only two were in
solidly positive territory with the biggest gains in the energy
sector and materials, both up almost 1%.
Here is your opening snapshot:



(Sinéad Carew)
*****


S&P 500: ANOTHER DASHBOARD LIGHT TURNS ON (0900 EST/1400
GMT)
The S&P 500 ended Friday at a fresh record high after
tacking on 16.3% in 2020. To get there, the benchmark index
advanced about 68% off its March 2020 closing low.
With this, in a sign of what may be an especially overheated
market, the percentage of S&P 500 stocks above their 200-day
moving average reached a more than 10-year high in early
December, when it hit 91.68%.
After dipping to about 88% on December 22, this measure
ended the year at about 91%. Although, only slightly below the
early December peak, it is nevertheless, weaker, despite the SPX
going to higher highs.
That said, it remains to be seen if this slight divergence
is enough to ultimately coincide with a SPX top of some form. Of
note, when the SPX peaked in February this measure had weakened
from a high of nearly 85% in January to about 76% when the SPX
topped on February 19th.
Meanwhile, another measure, based on the CBOE equity/put
call ratio, which can act as a contrarian measure of sentiment,
is suggesting the market is vulnerable to a reversal.




(Terence Gabriel)
*****


FOR MONDAY'S LIVE MARKETS' POSTS PRIOR TO 0900 EST/1400 GMT
- CLICK HERE:








(Terence Gabriel is a Reuters market analyst. The views
expressed are his own)

More News
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.